Molekulargenetisches Labor
Zentrum für Nephrologie und Stoffwechsel
Moldiag Erkrankungen Gene Support Kontakt

Fibrinogen alpha-Kette

Das FGA-Gen kodiert die alpha-Komponente des Fibrinogens, einem wichtigen Gerinnungsfaktor. Mutationen führen zu verschiedenen autosomal dominanten oder rezessiven Gerinnungsstörungen mit Blutungs- oder Thromboseneigung. Andere Mutationen können eine autosomal dominante viszeralen Amyloidose auslösen.

Gentests:

Klinisch Untersuchungsmethoden Familienuntersuchung
Bearbeitungszeit 5 Tage
Probentyp genomische DNS
Klinisch Untersuchungsmethoden Hochdurchsatz-Sequenzierung
Bearbeitungszeit 25 Tage
Probentyp genomische DNS
Klinisch Untersuchungsmethoden Direkte Sequenzierung der proteinkodierenden Bereiche eines Gens
Bearbeitungszeit 25 Tage
Probentyp genomische DNS

Verknüpfte Erkrankungen:

Nierenamyloidose
APOA1
Apolipoprotine A2-Amyloidose
APOA2
B2M
CST3
FGA
LYZ
Afibrinogenämie
FGA
FGB
FGG
Dysfibrinogenemie
FGA
FGB
FGG

Referenzen:

1.

Doolittle RF et al. (1970) The molecular constancy of fibrinopeptides A and B from 125 individual humans.

external link
2.

di Minno G et al. (1981) Effects of any epoxymethano stable analogue of prostaglandin endoperoxides (U-46619) on human platelets.

external link
3.

Jandrot-Perrus M et al. (1982) Fibrinogen Bondy: a new case of dysfibrinogenemia. Isolation of the abnormal fibrinogen molecules.

external link
4.

Crabtree GR et al. (1981) Molecular cloning of cDNA for the alpha, beta, and gamma chains of rat fibrinogen. A family of coordinately regulated genes.

external link
5.

Henry I et al. (1984) The genes coding for A alpha-, B beta-, and gamma-chains of fibrinogen map to 4q2.

external link
6.

Von Felten A et al. (1966) Familial disturbance of fibrin monomer aggregation.

external link
7.

Jackson DP et al. () Congenital disorders of fibrinogen.

external link
8.

Forman WB et al. (1968) An inherited qualitative abnormality in plasma fibrinogen: fibrinogen Cleveland.

external link
9.

Blombäck M et al. (1968) Fibrinogen Detroit--a molecular defect in the N-terminal disulphide knot of human fibrinogen?

external link
10.

Beck EA et al. (1971) Functional evaluation of an inherited abnormal fibrinogen: fibrinogen "Baltimore".

external link
11.

Gralnick HR et al. (1971) Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release.

external link
12.

Gralnick HR et al. (1972) Congenital dysfibrinogenemias.

external link
13.

Kant JA et al. (1983) The rat fibrinogen genes. Linkage of the A alpha and gamma chain genes.

external link
14.

Mammen EF et al. (1969) Congenital dysfibrinogenemia: fibrinogen Detroit.

external link
15.

Beck EA et al. (1965) A new inherited coagulation disorder caused by an abnormal fibrinogen ('fibrinogen Baltimore').

external link
16.

Streiff F et al. (1971) [A new case of Congenital and familial dysfibrinogenemia without Hemorrhagic Diathesis].

external link
17.

Crum ED et al. (1974) Fibrinogen Cleveland II. An abnormal fibrinogen with defective release of fibrinopeptide A.

external link
18.

Verhaeghe R et al. (1974) Fibrinogen 'Leuven', another genetic variant.

external link
19.

Doolittle RF et al. (1974) Platelet and plasma fibrinogens are identical gene products.

external link
20.

Soria J et al. (1972) Fibrinogen Troyes--fibrinogen Metz. Two new cases of congenital dysfibrinogenemia.

external link
21.

Ratnoff OD et al. (1973) The genetics of hereditary disorders of blood coagulation.

external link
22.

Hampton JW et al. (1972) Fibrinogen and fibrin-stabilizing factor.

external link
23.

Marder VJ et al. (1974) Fibrinogen and its derivatives, hereditary and acquired abnormalities.

external link
24.

Suh TT et al. (1995) Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice.

external link
25.

Xiao Q et al. (1998) Fibrinogen deficiency is compatible with the development of atherosclerosis in mice.

external link
26.

Brennan SO et al. (1995) Aberrant hepatic processing causes removal of activation peptide and primary polymerisation site from fibrinogen Canterbury (A alpha 20 Val --> Asp).

external link
27.

Mosesson MW et al. (1996) The relationship between the fibrinogen D domain self-association/cross-linking site (gammaXL) and the fibrinogen Dusart abnormality (Aalpha R554C-albumin): clues to thrombophilia in the "Dusart syndrome".

external link
28.

Fu Y et al. (1995) Fibrinogen alpha genes: conservation of bipartite transcripts and carboxy-terminal-extended alpha subunits in vertebrates.

external link
29.

Koopman J et al. (1993) Molecular basis for fibrinogen Dusart (A alpha 554 Arg-->Cys) and its association with abnormal fibrin polymerization and thrombophilia.

external link
30.

Branson HE et al. (1977) Fibrinogen Seattle: a qualitatively abnormal fibrinogen in a patient with tetralogy of Fallot.

external link
31.

Barthels M et al. (1977) [Fibrinogen "Hannover", a further abnormal fibrinogen].

external link
32.

Fuchs G et al. (1977) Fibrinogen Marburg a new genetic variant of fibrinogen.

external link
33.

Kudryk B et al. (1976) Fibrinogen Detroit - an abnormal fibrinogen with non-functinal NH2-terminal polymerization domain.

external link
34.

None (1993) Inherited dysfibrinogenemia: emerging abnormal structure associations with pathologic and nonpathologic dysfunctions.

external link
35.

Thomas A et al. (1994) Linkage disequilibrium across the fibrinogen locus as shown by five genetic polymorphisms, G/A-455 (HaeIII), C/T-148 (HindIII/AluI), T/G+1689 (AvaII), and BclI (beta-fibrinogen) and TaqI (alpha-fibrinogen), and their detection by PCR.

external link
36.

Neerman-Arbez M et al. (2000) Mutations in the fibrinogen aalpha gene account for the majority of cases of congenital afibrinogenemia.

external link
37.

Godal HC et al. (1978) Three new cases of an inborn qualitative fibrinogen defect (fibrinogen Oslo II).

external link
38.

McDonagh RP et al. (1980) Fibrinogen Chapel Hill: hypodysfibrinogenemia with a tertiary polymerization defect.

external link
39.

Higgins DL et al. (1981) Fibrinogen Petoskey, a dysfibrinogenemia characterized by replacement of Arg-A alpha 16 by a histidyl residue. Evidence for thrombin-catalyzed hydrolysis at a histidyl residue.

external link
40.

Olaisen B et al. (1982) Fibrinogen gamma chain locus is on chromosome 4 in man.

external link
41.

Crabtree GR et al. (1982) Coordinate accumulation of the mRNAs for the alpha, beta, and gamma chains of rat fibrinogen following defibrination.

external link
42.

Henschen A et al. (1983) Novel structure elucidation strategy for genetically abnormal fibrinogens with incomplete fibrinopeptide release as applied to fibrinogen Schwarzach.

external link
43.

Wehinger H et al. (1983) Hereditary hypofibrinogenemia with fibrinogen storage in the liver.

external link
44.

Soria J et al. (1983) Plasminogen Paris I: congenital abnormal plasminogen and its incidence in thrombosis.

external link
45.

Humphries SE et al. (1984) The identification of a DNA polymorphism of the alpha fibrinogen gene, and the regional assignment of the human fibrinogen genes to 4q26-qter.

external link
46.

Uzan G et al. (1984) Analysis of fibrinogen genes in patients with congenital afibrinogenemia.

external link
47.

Carter AM et al. (2000) alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism.

external link
48.

Fu Y et al. (1992) Carboxy-terminal-extended variant of the human fibrinogen alpha subunit: a novel exon conferring marked homology to beta and gamma subunits.

external link
49.

HASSELBACK R et al. (1963) Congenital hypofibrinogenemia in five members of a family.

external link
50.

Koopman J et al. (1992) Fibrinogen Marburg: a homozygous case of dysfibrinogenemia, lacking amino acids A alpha 461-610 (Lys 461 AAA-->stop TAA).

external link
51.

IMPERATO C et al. (1958) [Congenital hypofibrinogenemia with fibrinoasthenia].

external link
52.

Vlietman JJ et al. (2002) Congenital afibrinogenaemia in a newborn infant due to a novel mutation in the fibrinogen aalpha gene.

external link
53.

Akassoglou K et al. (2002) Fibrin inhibits peripheral nerve remyelination by regulating Schwann cell differentiation.

external link
54.

Asselta R et al. (2001) Congenital afibrinogenemia: mutations leading to premature termination codons in fibrinogen A alpha-chain gene are not associated with the decay of the mutant mRNAs.

external link
55.

Bolliger-Stucki B et al. (2001) Fibrinogen Milano XII: a dysfunctional variant containing 2 amino acid substitutions, Aalpha R16C and gamma G165R.

external link
56.

Drew AF et al. (2001) Wound-healing defects in mice lacking fibrinogen.

external link
57.

Martinez J et al. (1974) Fibrinogen Philadelphia. A hereditary hypodysfibrinogenemia characterized by fibrinogen hypercatabolism.

external link
58.

Collen A et al. (2001) Aberrant fibrin formation and cross-linking of fibrinogen Nieuwegein, a variant with a shortened Aalpha-chain, alters endothelial capillary tube formation.

external link
59.

Samama M et al. () [Congenital and familial dysfibrinogenemia without hemorrhagic tendancy].

external link
60.

Neerman-Arbez M et al. (1999) The 11 kb FGA deletion responsible for congenital afibrinogenaemia is mediated by a short direct repeat in the fibrinogen gene cluster.

external link
61.

Gralnick HR et al. (1979) Fibrinogen bethesda III: a hypodysfibrinogenemia.

external link
62.

Hamidi Asl L et al. (1997) Renal amyloidosis with a frame shift mutation in fibrinogen aalpha-chain gene producing a novel amyloid protein.

external link
63.

Uemichi T et al. (1996) A frame shift mutation in the fibrinogen A alpha chain gene in a kindred with renal amyloidosis.

external link
64.

Uemichi T et al. (1994) Hereditary renal amyloidosis with a novel variant fibrinogen.

external link
65.

Benson MD et al. (1993) Hereditary renal amyloidosis associated with a mutant fibrinogen alpha-chain.

external link
66.

None (1985) The United Kingdom Medical Research Council's glomerulonephritis registry.

external link
67.

Neerman-Arbez M et al. (1999) Deletion of the fibrinogen [correction of fibrogen] alpha-chain gene (FGA) causes congenital afibrogenemia.

external link
68.

Lefebvre P et al. (2004) Severe hypodysfibrinogenemia in compound heterozygotes of the fibrinogen AalphaIVS4 + 1G>T mutation and an AalphaGln328 truncation (fibrinogen Keokuk).

external link
69.

Lachmann HJ et al. (2002) Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis.

external link
70.

Ko YL et al. (2006) Functional polymorphisms of FGA, encoding alpha fibrinogen, are associated with susceptibility to venous thromboembolism in a Taiwanese population.

external link
71.

Blomback B et al. () Molecular defects and variants of fibrinogen.

external link
72.

Aznar J et al. (1974) Fibrinogen Valencia. A new case of congenital dysfibrinogenemia.

external link
73.

Soria J et al. (1985) Episodes of increased fibronectin level observed in a patient suffering from recurrent thrombosis related to congenital hypodysfibrinogenaemia (fibrinogen Malmoe).

external link
74.

Reber P et al. (1985) Fibrinogen Bergamo I (A alpha 16Arg----Cys): susceptibility towards thrombin following aminoethylation, methylation or carboxamidomethylation of cysteine residues.

external link
75.

Southan C et al. (1985) Fibrinogen Manchester. Detection of a heterozygous phenotype in the intraplatelet pool.

external link
76.

Marino MW et al. (1986) Chromosomal localization of human and rat A alpha, B beta, and gamma fibrinogen genes by in situ hybridization.

external link
77.

Ebert RF et al. (1986) Fibrinogen Seattle II: congenital dysfibrinogenemia with an Arg (A alpha 16)----his substitution.

external link
78.

Miyata T et al. (1987) Fibrinogens Kawaguchi and Osaka: an amino acid substitution of A alpha arginine-16 to cysteine which forms an extra interchain disulfide bridge between the two A alpha chains.

external link
79.

Alving BM et al. (1987) Fibrinogen giessen I: a congenital homozygously expressed dysfibrinogenemia with A alpha 16 Arg----His substitution.

external link
80.

Reber P et al. (1987) Fibrinogen Bergamo III and fibrinogen Torino: two further variants with hereditary molecular defects in fibrinopeptide A.

external link
81.

Siebenlist KR et al. (1988) Fibrinogen Birmingham: a heterozygous dysfibrinogenemia (A alpha 16 Arg----His) containing heterodimeric molecules.

external link
82.

Kant JA et al. (1985) Evolution and organization of the fibrinogen locus on chromosome 4: gene duplication accompanied by transposition and inversion.

external link
83.

Hamsten A et al. (1987) Genetic and cultural inheritance of plasma fibrinogen concentration.

external link
84.

Galanakis DK et al. (1989) Fibrinogen Stony Brook, a heterozygous A alpha 16Arg----Cys dysfibrinogenemia. Evaluation of diminished platelet aggregation support and of enhanced inhibition of fibrin assembly.

external link
85.

Arocha-Piñango CL et al. (1990) Fibrinogen Lima. A new dysfibrinogenaemia with a high-molecular-weight alpha-chain and effective polymerization.

external link
86.

Yoshida N et al. (1991) Fibrinogen Kyoto II, a new congenitally abnormal molecule, characterized by the replacement of A alpha proline-18 by leucine.

external link
87.

Lee MH et al. (1991) Fibrinogen Ledyard (A alpha Arg16----Cys): biochemical and physiologic characterization.

external link
88.

Mourad G et al. (2008) Cardiac amyloidosis with the E526V mutation of the fibrinogen A alpha-chain.

external link
89.

Flood VH et al. (2006) The fibrinogen Aalpha R16C mutation results in fibrinolytic resistance.

external link
90.

Maekawa H et al. (1991) An A alpha Ser-434 to N-glycosylated Asn substitution in a dysfibrinogen, fibrinogen Caracas II, characterized by impaired fibrin gel formation.

external link
91.

Maekawa H et al. (1992) Fibrinogen Lima: a homozygous dysfibrinogen with an A alpha-arginine-141 to serine substitution associated with extra N-glycosylation at A alpha-asparagine-139. Impaired fibrin gel formation but normal fibrin-facilitated plasminogen activation catalyzed by tissue-type plasminogen activator.

external link
92.

OMIM.ORG article

Omim 134820 external link
93.

Orphanet article

Orphanet ID 121786 external link
94.

NCBI article

NCBI 2243 external link
Update: 14. August 2020
Copyright © 2005-2020 Zentrum für Nephrologie und Stoffwechsel, Dr. Mato Nagel
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Deutschland, Tel.: +49-3576-287922, Fax: +49-3576-287944
Seitenüberblick | Webmail | Haftungsausschluss | Datenschutz